Repligen
RGEN
#2386
Rank
C$11.10 B
Marketcap
C$196.95
Share price
-5.71%
Change (1 day)
15.74%
Change (1 year)
Categories

Market capitalization of Repligen (RGEN)

Market cap: C$11.10 Billion

As of June 2026 Repligen has a market cap of C$11.10 Billion. This makes Repligen the world's 2386th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Repligen from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026C$11.10 B-13.29%
2025C$12.81 B9.5%
2024C$11.70 B-12.12%
2023C$13.31 B4.38%
2022C$12.75 B-31.64%
2021C$18.66 B39.58%
2020C$13.36 B112.5%
2019C$6.29 B99.41%
2018C$3.15 B58.78%
2017C$1.98 B41.81%
2016C$1.40 B8.37%
2015C$1.29 B71.7%
2014C$0.75 B62.46%
2013C$0.46 B137.95%
2012C$0.19 B79.69%
2011C$0.10 B-24.89%
2010C$0.14 B8.5%
2009C$0.13 B-7.18%
2008C$0.14 B-29.37%
2007C$0.20 B104.12%
2006C$99.41 M-29.11%
2005C$0.14 B34.8%
2004C$0.10 B-38.7%
2003C$0.16 B29.29%
2002C$0.13 B26.96%
2001C$0.10 B-23.09%
2000C$0.13 B33.61%
1999C$0.10 B183.76%
1998C$35.45 M76.5%
1997C$20.08 M-22.37%
1996C$25.87 M

End of Day market cap according to different sources

On Jun 28th, 2026 the market cap of Repligen was reported to be:

C$11.78 Billion
by Nasdaq info icon info icon
C$11.78 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
C$195.86 B 1,662.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
C$266.29 B 2,296.94%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
C$554.46 B 4,890.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$167.01 B 1,403.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
C$29.43 M-99.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C$2.13 B-80.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$24.09 B 116.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
C$15.70 B 41.40%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$15.67 B 41.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
C$15.13 B 36.21%๐Ÿ‡บ๐Ÿ‡ธ USA